# National Cancer Institute (NCI): Phase 2 study started recruiting, 126 planned (Acute Myeloid Leukemia)

**Score:** 85/100

| Field | Value |
|---|---|
| Sponsor | National Cancer Institute (NCI) |
| Sponsor type | NIH |
| Study | Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) |
| NCT ID | NCT07437950 |
| Phase | Phase 2 |
| Status | recruiting |
| Conditions | Acute Myeloid Leukemia |
| Intervention types | procedure, drug |
| Target enrollment | 126 |
| Site countries | United States, Puerto Rico |
| Posted | 2026-02-27 |
| Planned start | 2026-09-25 |
| Event | Started recruiting |
| Event date | 2026-09-25 |
| Last update posted | 2026-10-30 |

## Why this score
- Posted in the last two weeks.
- Just started recruiting: sites, recruitment and supply are active.
- Phase 2: multi-site, larger budget.
- 126 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07437950). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.